08/06/2026
WE ARE SO PROUD TO SHARE THIS. 🪩🐎🔬
The peer-reviewed clinical trial evaluating equicenta® CTM in performance horses is now available in Frontiers in Veterinary Science.
This is a major moment for the Equine Performance Labs team, for the veterinarians and researchers who helped make this study possible, and for the future of evidence-based equine musculoskeletal care.
In a multi-center, pragmatic prospective controlled trial of 138 performance horses, equicenta® CTM was associated with:
• Greater cumulative improvement in pain and swelling by Week 2
• Greater cumulative improvement in lameness by Week 4
• Better clinical outcomes through Week 12
• 2.72:1 odds of returning to or exceeding prior performance at 26 weeks compared with clinician-selected standard care
Real performance horses. Real-world cases. Peer-reviewed data.
We believe horses deserve more than promises. They deserve progress supported by science, rigorous research, and a team that refuses to settle for “good enough.”
To every veterinarian, researcher, horse owner, and performance horse who contributed to this work: thank you. This publication is a milestone we are incredibly proud to celebrate, and it is only the beginning. :test_tube: :racehorse: :tada:
Read the official announcement: https://www.businesswire.com/news/home/20260806853232/en/New-Multi-Center-Study-Shows-equicenta-CTM-Ready-to-Use-Equine-Umbilical-Cord-Allograft-Outperforms-Standard-of-Care-in-Returning-Performance-Horses-to-Work
Equine Performance Labs (EPL), the team behind equicenta® CTM — announced the publication of a peer-reviewed, prospective, controlled clinical trial demonstr...